Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
Fasting Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
Sponsor: Guangdong Provincial People's Hospital
A observational or N/A phase clinical study on All-cause Mortality and Cardiovascular Outcomes, this trial is ongoing. The trial is conducted by Guangdong Provincial People's Hospital and has accumulated 8 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2019 — Feb 2020 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangdong Provincial People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .